| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f506c417a3f3f88184448d3ca4440e8d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6b989015ad37849512ce846b3d2c928d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6f79749e86afce9444a364ab60ca3584
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_efa61b4abcfeaafa1b5d38a8f2c6ad8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec3d8ca6a7c6f903d61753ff5aa3a94c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3dc74b20cd59fbf18f713269b56aa16b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c2b4ed4f587b2eb2082d3905b8d0d195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_612fbbeef924a84eaac28e4d383490de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_507ced140bb0b0dfe8ab7d6d242703a8 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4406
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 |
| filingDate |
2010-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_038f9c8a4d40559ca0f22af90587c268
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d7a9253124d668f26c2a3406d9c2158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0e5bba06a552b584ba87339236b42cc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_673f8aa9c48129c41a30e61f8217240d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c07c33c756ea800ece103a0415508616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd426246e73175ff4eeaa2f41bc7a82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af7718dcbd19720b923fefba577af1a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9551b6188d2f62a724ad0c212167a5 |
| publicationDate |
2013-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8598345-B2 |
| titleOfInvention |
Substituted heteroarylamide analogs as mGluR5 negative allosteric modulators and methods of making and using the same |
| abstract |
Disclosed are negative allosteric modulators of the metabotropic glutamate receptor subtype 5 (mGluR5); synthetic methods for making the compounds; pharmaceutical compositions comprising the compounds; and methods of treating neurological and psychiatric disorders associated with glutamate dysfunction using the compounds and compositions. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9987242-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2014206707-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9844542-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9533982-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9550778-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9085562-B2 |
| priorityDate |
2009-09-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |